WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Seeks Comments on 2026 NRDL and Commercial Innovation Drug List Adjustmen... The NHSA has released draft proposals for the 2026 adjustment of the NRDL, as well as the Commercial Health Insurance Innovation Drug List, for public consultation before...
(5/11/2026)

China Emerges as Global Hub for siRNA Out-Lice... (5/11/2026)

A Strategic Playbook for Chinese Biotech Cross... (5/5/2026)

A Biopharmaceutical Superpower: China's Rise, ... (5/1/2026)

China Partnerships Drive Biopharma Deal Surge ... (4/29/2026)

From fast follower to originator: How Asia is ... (4/29/2026)

China Imposes Four-Year Deadline on Conditiona... (4/28/2026)

China Biopharma Financing Rebounds in March as... (4/27/2026)

China Biopharma Deal Activity Slows in Q1 2026... (4/22/2026)

China's Push to Elevate Private Health Insuran... (4/22/2026)

Chinese Biotech Commands One-Third of Global P... (4/21/2026)

China Deepens Opening of Biotech and Healthcar... (4/16/2026)

2026 Biotech Playbook: Hong Kong at the Centre... (4/16/2026)

Singapore, China Expand Regulatory Partn... (5/12/2026) Virax Eyes China Expansion for T-Cell Im... (5/12/2026) BrightGene Reports Phase 3 Success for D... (5/12/2026) Sihuan Pharma Completes Full H-Share Con... (5/12/2026) China Moves to Expand Maternity Insuranc... (5/12/2026) China Expands National Pediatric Medical... (5/12/2026) China Holds National Healthcare Reform M... (5/12/2026) BMS Strikes Up to $15.2B Hengrui Allianc... (5/12/2026) China Approves Novel EGFR, JAK2 Therapie... (5/12/2026) CureGene Raises Over CNY 300M in Series ... (5/12/2026) Resproly Raises New Funding to Advance I... (5/12/2026) DualityBio Reports Strong First-Line TNB... (5/12/2026) Starna Raises ~US$40M in Series B+ to Ad... (5/12/2026) CytoCares Reports First-in-Human AACR Da... (5/12/2026) BeOne Culls Multiple Early Oncology Prog... (5/12/2026) Sinocelltech Advances Dual Trispecific A... (5/12/2026) CDE Releases Draft MSC Stem Cell Product... (5/11/2026) NMPA Releases 105th Batch of Generic Dru... (5/11/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

Starna Raises ~US$40M in Series B+ to Advance In Vivo C... Resproly Raises New Funding to Advance Inhalation Pipel... CureGene Raises Over CNY 300M in Series C Led by Walvax BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate... Sihuan Pharma Completes Full H-Share Conversion of Xuan...

Singapore, China Expand Regulatory Partnership to Inclu... NHC Seeks Comments on Revised Human Genetic Resources R... NMPA Releases 105th Batch of Generic Drug Reference For... CDE Releases Draft MSC Stem Cell Product Guideline for ... China Unveils Tougher Nationwide Rules Governing Medica...

China Holds National Healthcare Reform Meeting, Priorit... China Expands National Pediatric Medical Center Network... China Moves to Expand Maternity Insurance Coverage and ... NHSA Seeks Comments on 2026 NRDL and Commercial Innovat... ZTE Partners With China's National Clinical Research Ce...

China Tightens Biopharma Supply Chain Controls, Raising... U.S. Lawmakers Push to Bar China Clinical Data From FDA... Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan...

Chinese API Makers Raise Prices as Middle East Conflict... India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as...

Sinocelltech Advances Dual Trispecific Antibody Combo I... BeOne Culls Multiple Early Oncology Programs, Halts Pha... CytoCares Reports First-in-Human AACR Data for CD19/CD3... DualityBio Reports Strong First-Line TNBC Data for DB-1... China Approves Novel EGFR, JAK2 Therapies as Wave of In...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Former NMPA Deputy Commissioner Sentenced to 14 Years f... Former Jiangxi Provincial Health Commission Chief Dismi... Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...